Data MATRIX Introduces an AI-Operated Patient Survival Assessment Tool
- Details
- Category: Events
Data MATRIX, a sole Real-World Evidence solutions provider in Russia, has presented a predictive analytics tool for estimating patient survival based on Real-World Data.
An important feature of the presented tool for predictive analysis of Real-World Data is its countrywide potential, and the ability to collect and analyze data on different patient cohorts.
Waiting Times for Medical Admissions Reduced by 34% at Bolton NHS Foundation Trust by New Clinically-Led Digital Solution
- Details
- Category: Allscripts
Clinicians at Bolton NHS Foundation Trust have dramatically reduced patient waiting times, decreased hospital length of stay and improved patient safety after developing an electronic acute medical list solution to manage patient referrals.
The configuration was initially set-up to track referrals and admissions to the Acute Medicine Unit (AMU) Team from multiple sources.
Clinerion Patent for Technology Underpinning Patient Network Explorer is Published
- Details
- Category: Industry
The new Clinerion patent underpins any medical EHR database infrastructure that incorporates a hybrid model of cloud-and-local server node installations at individual hospitals, as well as any method for search of patient cohort care metrics across such a platform. This allows real-time search at each individual hospital across the entire network at once, returning aggregate metrics from the entire network.
Using AI for Early Detection and Treatment of Illnesses
- Details
- Category: Research
Novel AI Blood Testing Technology can ID Lung Cancers with High Accuracy
- Details
- Category: Research
The test approach, called DELFI (DNA evaluation of fragments for early interception), spots unique patterns in the fragmentation of DNA shed from cancer cells circulating in the bloodstream.
Digital Health Webinar
- Details
- Category: Events
The digital healthcare ecosystem is evolving with rapid speed. Technologies such as AI, robotics, telemedicine, and precision medicine are a mix of challenges and opportunities. At the Digital Health Webinar, you will be introduced to digital medicine and DTx, novel wearables, data collection methods, regulatory issues, and other topics.
Bristol Myers Squibb Exercises Option to Develop Exscientia's AI-Designed, Immune-Modulating Drug Candidate
- Details
- Category: Industry
Exscientia, a clinical-stage, artificial intelligence (AI)-driven pharmatech company, today announced that Bristol Myers Squibb has elected to in-license an immune-modulating drug candidate created by Exscientia. Exscientia has two active collaborations with Bristol Myers Squibb, which together focus on multiple therapeutic areas, including oncology and immunology.
MEDICA is and Remains the International Platform for Start-Ups
- Details
- Category: Events
15 - 18 November 2021, Düsseldorf, Germany.The MEDICA start-up COMPETITION, the Healthcare Innovation World Cup, the MEDICA START-UP PARK and more than 100 start-ups with pitches in the MEDICA CONNECTED HEALTHCARE FORUM show that the world’s leading medical trade fair MEDICA in Düsseldorf has also established itself as the international platform for start-ups.
Abbott Receives FDA Clearance for its Imaging Technology Using AI
- Details
- Category: Industry
Abbott (NYSE: ABT) has received U.S. Food and Drug Administration (FDA) clearance for its latest optical coherence tomography (OCT) imaging platform powered by the company's new Ultreon Software. This innovative imaging software combines OCT with artificial intelligence (AI) to provide physicians an enhanced, comprehensive view of coronary blood flow and blockages to assist physician decision-making and provide the best pathway for treatment.
Artificial Intelligence in Medicine Regulation
- Details
- Category: Development
The International Coalition of Medicines Regulatory Authorities (ICMRA) sets out recommendations to help regulators to address the challenges that the use of artificial intelligence (AI) poses for global medicines regulation, in a report published today.
AI includes various technologies (such as statistical models, diverse algorithms and self-modifying systems) that are increasingly being applied across all stages of a medicine's lifecycle: from preclinical development, to clinical trial data recording and analysis, to pharmacovigilance and clinical use optimisation.